Question 1

What are the potential benefits of the combination treatment compared to standard chemotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis clinical trial (NCT01524094). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the surgery and chemotherapy be scheduled and what will recovery look like?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis clinical trial (NCT01524094). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of both treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis clinical trial (NCT01524094). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis clinical trial (NCT01524094). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks or reasons I might not qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis clinical trial (NCT01524094). Contact the study team or your healthcare provider for specific answers.

What this study is about